Trials / Completed
CompletedNCT04782180
PrEP at a Syringe Services Program
Mobile Delivery of PrEP at a Syringe Services Program-A Pilot Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to see if providing participants with pre-exposure prophylaxis (PrEP) medicine right away at the IDEA Exchange will help participants remain in HIV negative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Descovy 200Mg 25Mg Tablet | daily Descovy tab by mouth |
| BEHAVIORAL | PrEP | PrEP will be provided in a community setting by community-based harm reduction program. |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2024-11-11
- Completion
- 2024-11-11
- First posted
- 2021-03-04
- Last updated
- 2025-12-19
- Results posted
- 2025-12-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04782180. Inclusion in this directory is not an endorsement.